BENITO SIMON X 4
4 · INOVIO PHARMACEUTICALS, INC. · Filed Mar 17, 2022
Insider Transaction Report
Form 4
BENITO SIMON X
Director
Transactions
- Exercise/Conversion
Common Stock
2022-03-16$2.20/sh+2,000$4,400→ 59,305 total - Exercise/Conversion
Common Stock Options
2022-03-16−2,000→ 6,000 totalExercise: $2.20From: 2012-08-10Exp: 2022-08-10→ Common Stock (2,000 underlying) - Sale
Common Stock
2022-03-16$3.16/sh−2,000$6,320→ 57,305 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014.